Interpace Biosciences (IDXG) Reports Q3 EPS of $0.04

Interpace Biosciences (OTC: IDXG) reported Q3 EPS of $0.04. Revenue for the quarter came in at $8.76 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Kepler Cheuvreux Upgrades Swissquote Group Holding SA (SQN:SW) to Buy
• Citi reiterates Buy rating on SanDisk with $2,100 target